CHRYSTAL RHOADES: Open Payments
NPI 1861014151 · PATASKALA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 42 payments from 14 companies in 2025. Trend: 2023 $79 · 2024 $514 · 2025 $773
Food & beverage: $773
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $205 |
| Novo Nordisk Inc | 6 | $108 |
| PFIZER INC. | 5 | $108 |
| Esperion Therapeutics, Inc. | 3 | $55 |
| Kestra Medical Technology Services, Inc. | 2 | $50 |
| Amgen Inc. | 3 | $47 |
| ABIOMED | 1 | $44 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| BridgeBio Pharma, Inc. | 1 | $24 |
| Edwards Lifesciences Corporation | 1 | $21 |
Products named: LEQVIO, VYNDAQEL, Wegovy, NEXLETOL, Assure WCD, REPATHA, VERQUVO, Attruby.
Industry payments across OH — which companies pay providers there.
